{
    "eid": "2-s2.0-85075134767",
    "title": "Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies",
    "cover-date": "2019-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Somratai Vadcharavivad",
        "Warangkana Saengram",
        "Annop Phupradit",
        "Nalinee Poolsup",
        "Wiwat Chancharoenthana"
    ],
    "citedby-count": 6,
    "ref-count": 47,
    "ref-list": [
        "Improving Global Outcomes Transplant Work Group (KDIGO) clinical practice guideline for the care of kidney transplant recipients",
        "Modified release tacrolimus",
        "Modified-release tacrolimus",
        "Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations",
        "Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation",
        "Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients",
        "Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure",
        "Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients",
        "Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation",
        "Treatment satisfaction in renal transplant patients taking tacrolimus once daily",
        "Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence",
        "Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study",
        "Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management",
        "Once- versus twice-daily tacrolimus: are the formulations truly equivalent?",
        "Extended release versus immediate release tacrolimus in kidney transplant recipients: a systematic review and meta-analysis",
        "Effects of obesity on kidney transplantation outcomes: a systematic review and meta-analysis",
        "ABO-incompatible kidney transplant outcomes: a meta-analysis",
        "Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis",
        "Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of observational studies in epidemiology (MOOSE) group",
        "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation",
        "Prediction of creatinine clearance from serum creatinine",
        "ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions",
        "Measuring inconsistency in meta-analyses",
        "Bias in meta-analysis detected by a simple, graphical test",
        "De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels",
        "Extended-release tacrolimus therapy in de novo kidney transplant recipients: single-center experience",
        "Therapeutic drug monitoring in de novo kidney transplant receiving the modified-release once-daily tacrolimus",
        "A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome study",
        "Clinical experience with once\u2013daily tacrolimus in de novo kidney transplant recipients from living donors in Japan: 1\u2013year follow up",
        "Protocol biopsy findings in living donor kidney transplant patients treated with once-daily or twice-daily tacrolimus formulation",
        "Prograf produces more benefits for CYP3A5 low expression patients in early stage after kidney transplantation",
        "Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations",
        "Incidence of donor-specific anti-HLA antibodies in Non-HLA-sensitized patients given tacrolimus once or twice daily during the first 2 years after kidney transplant",
        "Real-World Study of once-daily, extended-release tacrolimus versus twice-daily, immediate-release tacrolimus in kidney transplantation: clinical outcomes and healthcare resource utilization",
        "Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study",
        "The impact of acute rejection episodes on longterm graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens",
        "Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients",
        "Absence of deleterious effect on longterm kidney graft survival of rejection episodes with complete functional recovery",
        "Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes",
        "Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation",
        "Clinical pharmacokinetics of once daily tacrolimus in solid-organ transplant patients",
        "Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients",
        "Differential impact of the CYP3A5*1 and CYP3A5*3 alleles on pre-dose concentrations of two tacrolimus formulations",
        "Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients",
        "Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation",
        "CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60031451",
            "affilname": "Thammasat University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031451",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Aranyaprathet",
            "@id": "123463324",
            "affilname": "Samrejvittaya School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123463324",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Faculty of Pharmaceutical Sciences of Chulalongkorn University"
    ]
}